Related references
Note: Only part of the references are listed.Visualizing and interpreting cancer genomics data via the Xena platform
Mary J. Goldman et al.
NATURE BIOTECHNOLOGY (2020)
Long noncoding RNA PiHL regulates p53 protein stability through GRWD1/RPL11/MDM2 axis in colorectal cancer
Xuan Deng et al.
THERANOSTICS (2020)
Puerarin attenuates neurological deficits via Bcl-2/Bax/cleaved caspase-3 and Sirt3/SOD2 apoptotic pathways in subarachnoid hemorrhage mice
Yu Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Roles of p21, p53, cyclin D1, CDK-4, estrogen receptor in aflatoxin B1-induced cytotoxicity in testicular tissue of mice
Toraj Zamir-Nasta et al.
ENVIRONMENTAL TOXICOLOGY (2018)
UBAP2L silencing inhibits cell proliferation and G2/M phase transition in breast cancer
Jing He et al.
BREAST CANCER (2018)
p16, p21, and p53 proteins play an important role in development of pancreatic intraepithelial neoplastic
Justyna Zinczuk et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2018)
Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells
Zsofia Turi et al.
CELL CYCLE (2018)
GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis
Kota Kayama et al.
EMBO REPORTS (2017)
Low frequency mutations in ribosomal proteins RPL10 and RPL5 in multiple myeloma
Isabel J. F. Hofman et al.
HAEMATOLOGICA (2017)
Competing memories of mitogen and p53 signalling control cell-cycle entry
Hee Won Yang et al.
NATURE (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Low frequency mutations in ribosomal proteins RPL10 and RPL5 in multiple myeloma
Isabel J. F. Hofman et al.
HAEMATOLOGICA (2017)
MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways
Lingyu Zhao et al.
EBIOMEDICINE (2017)
The p53/p21 Complex Regulates Cancer Cell Invasion and Apoptosis by Targeting Bcl-2 Family Proteins
Eun Mi Kim et al.
CANCER RESEARCH (2017)
The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes
Martin Fischer et al.
NUCLEIC ACIDS RESEARCH (2016)
MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
Manish Neupane et al.
CANCER DISCOVERY (2016)
p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence
F Sawair et al.
Asian Pacific Journal of Cancer Prevention (2016)
DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac
Yafang Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Nucleolar repression facilitates initiation and maintenance of senescence
Leixiang Yang et al.
CELL CYCLE (2015)
Down-regulation of 5S rRNA by miR-150 and miR-383 enhances c-Myc-rpL11 interaction and inhibits proliferation of esophageal squamous carcinoma cells
Xinyu Wang et al.
FEBS LETTERS (2015)
Variant Rett syndrome in a girl with a pericentric X-chromosome inversion leading to epigenetic changes and overexpression of the MECP2 gene
Jose Pedro Vieira et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2015)
Partial Loss of Rpl11 in Adult Mice Recapitulates Diamond-Blackfan Anemia and Promotes Lymphomagenesis
Lucia Morgado-Palacin et al.
CELL REPORTS (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase
R. Chaturvedi et al.
ONCOGENE (2015)
Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis
Sladana Bursac et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Non-genotoxic activation of p53 through the RPL11-dependent ribosomal stress pathway
Lucia Morgado-Palacin et al.
CARCINOGENESIS (2014)
Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle
Vanessa Oakes et al.
CELL CYCLE (2014)
TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers
Balazs Gyorffy et al.
MOLECULAR ONCOLOGY (2014)
Epigenetic silencing of methyl-CpG-binding protein 2 gene affects proliferation, invasion, migration, and apoptosis of human osteosarcoma cells
Gang Meng et al.
TUMOR BIOLOGY (2014)
PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression
R. Uchi et al.
BRITISH JOURNAL OF CANCER (2013)
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia
Kim De Keersmaecker et al.
NATURE GENETICS (2013)
Knock-down of methyl CpG-binding protein 2 (MeCP2) causes alterations in cell proliferation and nuclear lamins expression in mammalian cells
Federica Babbio et al.
BMC CELL BIOLOGY (2012)
MeCP2 Binds to 5hmC Enriched within Active Genes and Accessible Chromatin in the Nervous System
Marian Mellen et al.
CELL (2012)
Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint
Stefano Fumagalli et al.
GENES & DEVELOPMENT (2012)
Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11
Masato Sasaki et al.
NATURE MEDICINE (2011)
Recent advances in MeCP2 structure and function
Kristopher C. Hite et al.
BIOCHEMISTRY AND CELL BIOLOGY (2009)
Signaling to p53: Ribosomal Proteins Find Their Way
Yanping Zhang et al.
CANCER CELL (2009)
How Common Are Extraribosomal Functions of Ribosomal Proteins?
Jonathan R. Warner et al.
MOLECULAR CELL (2009)
Ribosomal Protein S7 Is Both a Regulator and a Substrate of MDM2
Yan Zhu et al.
MOLECULAR CELL (2009)
Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells
I. Neganova et al.
ONCOGENE (2009)
MeCP2, a key contributor to neurological disease, activates and represses transcription
Maria Chahrour et al.
SCIENCE (2008)
Putting a finger on growth surveillance -: Insight into MDM2 zinc finger-ribosomal protein interactions
Mikael S. Lindstrom et al.
CELL CYCLE (2007)
BioGRID: a general repository for interaction datasets
Chris Stark et al.
NUCLEIC ACIDS RESEARCH (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis
N Ballas et al.
CELL (2005)
Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions
HD Chae et al.
ONCOGENE (2004)
DNA binding of methyl-CpG-binding protein MeCP2 in human MCF7 cells
C Koch et al.
BIOCHEMISTRY (2004)
Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer
E Ballestar et al.
EMBO JOURNAL (2003)
MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status
HM Müller et al.
BRITISH JOURNAL OF CANCER (2003)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
The p53-Mdm2 module and the ubiquitin system
D Michael et al.
SEMINARS IN CANCER BIOLOGY (2003)
Share Paper
